Global Push to Fast-Track Bundibugyo Ebola Vaccines Amid Insecurity
TL;DR
With no approved vaccine or treatment yet for the Bundibugyo Ebola strain spreading in the DRC and Uganda, about $60 million in emergency funding is aimed at accelerating vaccine candidates (IAVI's rVSV Bundibugyo and Oxford's ChAdOx1 Bundibugyo) and potential treatments (MBP134, Maftivimab, remdesivir), plus a preventive drug trial. Trials are hampered by security issues in the affected region, delaying site setup and testing. Timelines vary from a couple of months to seven–nine months before trials can begin, and operational realities may slow progress despite scientific readiness.
- The race to combat Ebola: what vaccines and treatments are being developed and how long will it take? The Guardian
- What will it take to get a vaccine for the Ebola strain driving the current outbreak? NPR
- CEPI fast-tracks three Bundibugyo ebolavirus vaccine candidates CEPI
- What are the Ebola vaccines under research, and when will they be ready? Al Jazeera
- As Ebola Spreads, Scientists Race to Find Vaccines and Treatments The New York Times
Want the full story? Read the original reporting
Read on The Guardian